Demographic Distribution and Analysis of Hospital Morbidity due to Malignant Esophageal Neoplasm in Brazil: An Observational Study Using SUS Data (2022–2025)

Authors

  • Eduarda Ienerich Marciano Universidade de Cuiabá
  • Luiggi Universidade de Cuiabá
  • Maria Júlia Ribeiro de Rezende Universidade de Cuiabá
  • Rafael Sousa Faleiros Universidade de Várzea Grande
  • Iza Faleiros Coutinho Tiago Universidade de Cuiabá
  • Ari Coutinho Tiago Saldiba Neto Universidade de Cuiabá
  • Gabriel Estevão Tortorelli Vaz Curvo Universidade de Cuiabá
  • Maria Eduarda Bongiovanni Universidade de Cuiabá
  • Victoria Gomes Cosendei Universidade de Cuiabá
  • Rafhaela Szulczewski Universidade de Cuiabá
  • Nayana Goerck de Almeida Universidade de Cuiabá
  • Felipe Augusto Moisés Miquelin Universidade de Cuiabá

DOI:

https://doi.org/10.36557/2674-8169.2026v8n4p817-827

Keywords:

Esophageal neoplasms; Hospital morbidity; Epidemiology; Unified Health System; Public health.

Abstract

Esophageal cancer is a highly lethal malignancy with significant public health impact, showing higher incidence among males and older age groups. This study aimed to analyze hospital morbidity due to malignant esophageal neoplasm in Brazil, according to age group and sex, from 2022 to 2025. This is an epidemiological, observational, descriptive, and retrospective study based on secondary data from the Hospital Information System of the Brazilian Unified Health System (SIH/SUS), available through DATASUS. Hospitalizations due to malignant esophageal neoplasm, classified according to ICD-10, were analyzed considering sex and age group variables. During the study period, there was a marked predominance of hospitalizations among males, with higher concentration in individuals aged 50 to 69 years, particularly between 60 and 69 years. A progressive increase in hospitalizations with advancing age was observed up to the sixth decade of life, followed by a slight decline in older age groups. These findings reinforce the association between cumulative risk factors and disease development, as well as suggest late diagnosis. It is concluded that esophageal cancer remains an important public health issue in Brazil, highlighting the need for strategies focused on prevention, early diagnosis, and control of risk factors, especially among vulnerable populations.

Downloads

Download data is not yet available.

References

AGUIAR, D. L. et al. Análise epidemiológica da incidência de neoplasias malignas do esôfago no Piauí: dados dos últimos 5 anos. Lumen et Virtus, [S. l.], v. 15, n. 41, p. 5853–5863, 2024. DOI: 10.56238/levv15n41-068. Disponível em: https://periodicos.newsciencepubl.com/LEV/article/view/912. Acesso em: 24 jan. 2025.

BRASIL. Ministério da Saúde. Estimativas da incidência e mortalidade por câncer no Brasil, 2010. Rio de Janeiro: INCA, 2010.

ENZINGER, P. C.; MAYER, R. J. Esophageal cancer. New England Journal of Medicine, v. 349, n. 23, 2003.

FERLAY, J. et al. Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA: A Cancer Journal for Clinicians, v. 71, n. 3, p. 209-249, 2021. Disponível em: https://pubmed.ncbi.nlm.nih.gov/33538338/. Acesso em: 24 jan. 2025.

FERREIRA, J. R.; SOUZA, M. L.; LIMA, P. C. Epidemiologia e características clínicas do carcinoma esofágico. Revista Brasileira de Oncologia, v. 67, n. 3, p. 215-222, 2021.

GARRIDO, P. et al. Immunotherapy and targeted therapy for esophageal cancer. Gastroenterology, v. 158, n. 4, p. 930-945, 2020.

HULL, M. A. et al. Risk factors for esophageal cancer: a review of the epidemiology, pathogenesis, and treatment outcomes. Journal of Gastrointestinal Oncology, v. 11, n. 4, p. 555-567, 2020. Disponível em: https://pubmed.ncbi.nlm.nih.gov/33436519/. Acesso em: 24 jan. 2025.

LANGER, C. J. et al. Current and future management of esophageal cancer. Journal of Clinical Oncology, v. 39, n. 16, p. 1790-1800, 2021.

MOREIRA, G. P.; ALVES, T. R.; BARBOSA, D. M. Carcinoma de esôfago: sintomas iniciais e importância do diagnóstico precoce. Journal of Clinical Cancer Research, v. 12, n. 1, p. 55-62, 2019.

SHEA, M. et al. Esophageal cancer: epidemiology, risk factors, and treatment outcomes. Journal of Gastrointestinal Oncology, v. 12, n. 6, p. 1378-1392, 2021. Disponível em: https://pubmed.ncbi.nlm.nih.gov/33436519/. Acesso em: 24 jan. 2025.

SIEWERT, J. R. et al. Histologic tumor type is an independent prognostic parameter in esophageal cancer. Annals of Surgery, v. 234, p. 360–369, 2001.

SILVA, A. B.; OLIVEIRA, F. T. Aspectos clínicos e diagnósticos do câncer de esôfago: revisão de literatura. Revista de Gastroenterologia Clínica, v. 45, n. 2, p. 143-150, 2020.

SOUZA, J. A. et al. Tratamento do câncer de esôfago no Brasil: avanços e desafios. Revista Brasileira de Cancerologia, v. 68, n. 1, p. 22-30, 2022.

WONG, M. C. S. et al. Global incidence and mortality of esophageal cancer: a systematic review and meta-analysis. Cancer Epidemiology, v. 45, p. 1-12, 2016. Disponível em: https://www.journals.elsevier.com/cancer-epidemiology. Acesso em: 28 jan. 2025.

Published

2026-04-18

How to Cite

Ienerich Marciano, E., Luiggi, Ribeiro de Rezende, M. J., Sousa Faleiros , R., Faleiros Coutinho Tiago , I., Coutinho Tiago Saldiba Neto , A., Estevão Tortorelli Vaz Curvo, G., Bongiovanni, M. E., Gomes Cosendei, V., Szulczewski , R., Goerck de Almeida , N., & Augusto Moisés Miquelin , F. (2026). Demographic Distribution and Analysis of Hospital Morbidity due to Malignant Esophageal Neoplasm in Brazil: An Observational Study Using SUS Data (2022–2025). Brazilian Journal of Implantology and Health Sciences, 8(4), 817–827. https://doi.org/10.36557/2674-8169.2026v8n4p817-827